Egypt
Egypt is the most populated country in the MENA region and therefore a key country in clinical research and for CRO. Many KOL among almost all therapeutic area can be found in Egypt in public hospital (clinical research is actually not allowed in private sector). MCT cover Egypt from it new Maadi office since early 2010 and has conducted many clinical projects especially in indication related to liver diseases (HCV, HCC,…), Diabetes and Oncology. MCT was the first CRO being approved by local MOH in early 2013.
Country details
- Population: 80 millions
- Capital: Cairo
- Languages: Arabic
- Main cities: Alexandria, Port Said, Suez
- Others datas
Regulatory
- Submission process: Sequential process (LEC and then MOH)
- Competent authority: MOH Egypt (http://www.mohp.gov.eg/default.aspx)
Number of clinical trials: 432 (source database www.clinicaltrials.gov in April 2013)
MCT coverage: MCT office based in New Maadi-Cairo
CRO services provided in Egypt:
- Sites selection/ Feasibility
- Regulatory submissions
- Monitoring
- Project Management
- Pharmacovigilance
- Training & Quality Assurance
- Staff Outsourcing (CRA, Senior CRA, CTA, Project Manager, Study coordinators)